2024 Global Antisense & RNAi Therapeutics Market Report: Key Drivers, Size, and Leading Segments
Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What Growth Rate is Predicted for the Antisense & RNAi Therapeutics Market for 2024-2033?
The market size for antisense & rnai therapeutics has seen a speedy expansion in the recent past. The market is predicted to rise from $1.59 billion in 2023 to $1.77 billion in 2024, marking a compound annual growth rate (CAGR) of 11.4%. The noteworthy growth during the historical timeframe is due to increased funding, technological advancements, augmented healthcare spending, swift increase in the senior population, and economic upturn in developing markets.
In the coming years, the market for antisense & rnai therapeutics is anticipated to witness a rapid surge in growth. The market is projected to increase in size to $2.81 billion by 2028, boasting a CAGR of 12.3%. Various factors can be credited to this predicted growth during the forecast period, such as enhanced access to healthcare, an increasing trend in cancer prevalence, and a boost in demand for antisense and rnai therapeutics because of the covid-19 pandemic. In the same forecast period, notable trends are expected to include concentrated efforts in the research and development of RNA therapeutics for rare diseases, the use of nanoparticle technology, the creation of new and enhanced antisense and rnai therapeutics, and collaborations with different companies for product innovation and revenue growth enhancement.
Claim Your Free Sample of the Global Antisense & RNAi Therapeutics Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=3389&type=smp
What Drivers Are Enhancing the antisense & rnai therapeutics Market’s Growth?
The escalating cases of coronary artery problems, neurodegenerative disorders, and infectious diseases are anticipated to boost the demand for the antisense & RNAi therapeutics market. Gene suppression strategies such as RNA interference and antisense oligonucleotides are employed for the treatment of numerous neurodegenerative diseases by rectifying mutant genes. As per the National Institute of Environmental Health Sciences, Alzheimer’s disease and Parkinson’s disease are the most prevalent neurodegenerative conditions impacting millions worldwide. In the USA, around 6.2 million people might have Alzheimer’s disease. According to January 2023 data, roughly 500,000 people in the USA have been diagnosed with Parkinson’s disease. Thus, the rising incidence of several neurodegenerative diseases and infectious diseases is predicted to propel the growth of the antisense & RNAi therapeutics market.
What Segments Are Central to the Antisense & RNAi Therapeutics Market?
1) By Technology: RNA Interference, Antisense RNA
2) By Route of Administration: Intravenous Injections, Intra-dermal Injections, Other Delivery Methods
3) By Indication: Oncology, Cardiovascular Diseases (CVDs), Respiratory Disorders, Neurological Disorders, Infectious Diseases, Other Indications
What Emerging Trends Are Influencing Antisense & RNAi Therapeutics Industry Dynamics?
In the antisense & RNAi therapeutics market, leading companies are adopting strategic moves like partnerships and collaborations to hold their ground amid mounting competition. Such strategic collaborations involve two or more firms working jointly towards a shared goal or objective. For instance, in January 2023, Orbit Discovery Limited, an American firm that provides peptide discovery services, entered into a partnership with UK-based SanegeneBio Inc. which specializes in creating novel RNAi-based medicines. The partnership is aimed at identifying tissue-specific RNA therapeutics delivery for effective gene knockdown, with an end goal of developing an advanced RNAi therapeutics portfolio. The partnership includes hit identification and internalization studies conducted within cells, while Sanegene has the option to further work on the hits generated from the screening procedures, utilizing Orbit’s exclusive technology for swift peptide lead discovery. Orbit Discovery’s unique peptide display engine facilitates the screening of extensive peptide libraries, allowing for a faster discovery of pertinent peptide leads based on affinity and functional screens.
Order Now for Fast Delivery of Your Antisense & RNAi Therapeutics Market Report!
Which Geographic Locations Are Critical to the Growth of the Antisense & RNAi Therapeutics Market?
North America was the largest region in the antisense & RNAi therapeutics market in 2023. The regions covered in the antisense & rnai therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The Antisense & RNAi Therapeutics Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the antisense & rnai therapeutics market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Antisense & RNAi Therapeutics Market Include
1. Antisense & RNAi Therapeutics Market Executive Summary
2. Antisense & RNAi Therapeutics Market Segments
3. Antisense & RNAi Therapeutics Market Size And Template Market Growth Rate
4. Key Antisense & RNAi Therapeutics Market Trends
5. Major Antisense & RNAi Therapeutics Market Drivers
……
25. Key Mergers And Acquisitions In The Antisense & RNAi Therapeutics Market
26. Top Antisense & RNAi Therapeutics Companies
27. Antisense & RNAi Therapeutics Market Opportunities And Strategies
28. Antisense & RNAi Therapeutics Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Anti-Hypertensive Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/anti-hypertensive-drugs-global-market-report
Neurodegenerative Disorder Therapeutics Global Market Report 2024
Biosimilar Hormones Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/biosimilar-hormone-global-market-report
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
